Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ Kiran-Mazumdar-Shaw ]

Results 1 to 11 of 11
Kiran Mazumdar Shaw, Executive Chairperson, Biocon
New Delhi, August 5, 2020
Mining of huge data will enhance the probability of finding new drugs, making India the laboratory of the world


Kiran Mazumdar-Shaw
January 31, 2020
Greater investment in biological sciences is crucial because we are in times when both non-communicable diseases (like cancer and diabetes) and infectious diseases (caused by new viruses) are only going to rise


Kiran Mazumdar Shaw
February 2, 2018
The Union Budget needed to be prudent and forward-looking rather than populist and that is exactly what Finance Minister Arun Jaitley has achieved through some very smart schemes announced in the areas of healthcare, Science & Technology (S&T), agriculture and rural infrastructure.


Kiran Mazumdar-Shaw, CMD , Biocon
February 29, 2016
Infra and Agri are the two key sectors that are beneficiaries of Budget 2016.


Kiran Mazumdar-Shaw
February 11, 2016
The Budget needs to create conditions for higher investments in R&D-led start-ups to prepare the path for value accretive and non-linear growth.


Kiran Mazumdar- Shaw
February 8, 2016
I hope the forthcoming Budget will see increased public healthcare spending from the current abysmal 1 per cent level to a more credible 2.5 per cent of GDP in order to address the burgeoning healthcare challenges India is facing.


Kiran Mazumdar-Shaw
March 3, 2015
It may not have been the 'Big Bang' Budget that most were expecting, but Mr Jaitley has succeeded in creating a pro-growth and pro-investment roadmap.


Kiran Mazumdar-Shaw
February 20, 2015
This Budget would have to be about decisive action and must give a time-bound roadmap for economic revival.


Kiran Mazumdar-Shaw
May 26, 2014
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon on the five issues that need to be addressed in pharmaceuticals by the new Narendra Modi government:


Kiran Mazumdar-Shaw
February 17, 2014
Biocon chairman and managing director Kiran Mazumdar-Shaw says industry was not expecting much from the budget in the first place.  However, even the relief measures announced for the manufacturing sector, automobiles, blood banks and others, are token measures, feels Mazumdar-Shaw.


Kiran Mazumdar-Shaw
June 18, 2013
The issuing of manufacturing licences should be strictly regulated and the frequency of spot audits stepped up along with severe penalties for non-compliance, writes Biocon CMD Kiran Mazumdar-Shaw.


PAGES 1 OF 1